Personal Details
Doctor Name Dr. Sana Syed, MD
Primary Specialty Neuroimmunology/multiple Sclerosis and Dementia
Subspecialty Neuroimmunology and Dementia

Initial Consultation: $
Follow-up Patient Fee: $

Detailed Profile

Residency:
Boston Medical Center, Boston, MA

Fellowship:
Beth Israel Deaconess Medical Center, Boston, MA
Cognitive Neurology Fellow, Department of Neurology  
Multiple Sclerosis Fellow, Department of Neurology 

Certifications:
Diplomate American Board of Psychiatry and Neurology (ABPN)
Expanded Disability Status Scale (EDSS)

Conditions Treated

  • Migraine and other Headache Disorders
  • Neuropathy
  • Alzheimer’s disease
  • Multiple sclerosis
  • Tremors
  • Demyelinating disorders
  • Dementia
  • Frontotemporal dementia
  • Vascular dementia
  • TBI
  • ADD/ADHD
  • Cognitive impairment in systemic disorders
  • Neuro-sarcoidosis

Biography
Dr. Sana Syed is a neurologist with special expertise in taking care of patients with multiple sclerosis and other demyelinating diseases, and dementia and other cognitive disorders. Dr. Syed completed her residency training at Boston Medical Center, Boston, MA and fellowships in Cognitive Neurology and Multiple Sclerosis at Beth Israel Deaconess Medical Center, Boston, MA. Additionally Dr. Syed has a Masters in Public Health from the Harvard School of Public Health. Her expertise also include designing and leading clinical trials for neurological disorders.

Research/Work Interests

  • To design and lead clinical trials for neuropsychiatric disorders including demyelinating diseases, cognitive disorders, neurodegenerative diseases and other neuroinflammatory disorders
  • To incorporate novel design methodologies to optimize the outcomes assessment and potential success of the trial
  • To work in a matrix environment that allows for the free flow of ideas and encourages a dynamic perspective
  • To develop strategies that incorporate multidisciplinary principles (statistics, clinical and regulatory) to allow for innovative and disruptive clinical trial development
  • To optimize bedside assessments of attentional deficits. Assessment and treatment of patients with dementia and multiple sclerosis
  • Developing educational programs for residents and medical students on translational and pharmaceutical research across academic and pharmaceutical domains